IGI, Inc. Names New Chief Executive Officer

Apr 18, 2001, 01:00 ET from IGI, Inc.

    BUENA, N.J., April 18 /PRNewswire/ -- IGI, INC. (Amex:   IG) today announced
 that Robert E. McDaniel has submitted his resignation as Chief Executive
 Officer and Secretary of the Company.  Mr. McDaniel will provide consulting
 services to the Company and will remain as a nominee to serve on the Company's
 Board of Directors.  The Executive Committee of the Board of Directors has
 designated John Ambrose, President, to serve as Interim Chief Executive
 Officer, pending action by the full Board of Directors on a permanent Chief
 Executive Officer.  The Board is expected to consider the matter following the
 annual meeting of shareholders on May 16, 2001.
     IGI is a company committed to grow by applying its technologies to deliver
 cost-effective solutions to customer's problems.  IGI solves problems in
 consumer and skin care markets and pet care markets.  An increasing number of
 IGI's solutions are based on the patented Novasome(R) microencapsulation
 technology which offers value-added qualities to cosmetics, skin care
 products, chemicals, biocides, pesticides, fuels, medicines, foods, beverages,
 pet care products and other products.
 
     This report contains forward-looking statements relating to IGI's hopes
 and expectations for the future.  For this purpose, any statements contained
 herein that are not statements of historical fact may be deemed to be forward-
 looking statements.  Without limiting the foregoing, words such as "will",
 "possible", "one time", "provides an opportunity", "continue" and similar
 expressions are intended to identify forward-looking statements.  Such
 statements involve a number of risks and uncertainties and actual future
 events and results could differ materially from those indicated by such
 forward-looking statements due to general economic conditions, and the risk
 factors detailed in IGI's periodic reports and registration statements filed
 with the Securities and Exchange Commission.
 
 

SOURCE IGI, Inc.
    BUENA, N.J., April 18 /PRNewswire/ -- IGI, INC. (Amex:   IG) today announced
 that Robert E. McDaniel has submitted his resignation as Chief Executive
 Officer and Secretary of the Company.  Mr. McDaniel will provide consulting
 services to the Company and will remain as a nominee to serve on the Company's
 Board of Directors.  The Executive Committee of the Board of Directors has
 designated John Ambrose, President, to serve as Interim Chief Executive
 Officer, pending action by the full Board of Directors on a permanent Chief
 Executive Officer.  The Board is expected to consider the matter following the
 annual meeting of shareholders on May 16, 2001.
     IGI is a company committed to grow by applying its technologies to deliver
 cost-effective solutions to customer's problems.  IGI solves problems in
 consumer and skin care markets and pet care markets.  An increasing number of
 IGI's solutions are based on the patented Novasome(R) microencapsulation
 technology which offers value-added qualities to cosmetics, skin care
 products, chemicals, biocides, pesticides, fuels, medicines, foods, beverages,
 pet care products and other products.
 
     This report contains forward-looking statements relating to IGI's hopes
 and expectations for the future.  For this purpose, any statements contained
 herein that are not statements of historical fact may be deemed to be forward-
 looking statements.  Without limiting the foregoing, words such as "will",
 "possible", "one time", "provides an opportunity", "continue" and similar
 expressions are intended to identify forward-looking statements.  Such
 statements involve a number of risks and uncertainties and actual future
 events and results could differ materially from those indicated by such
 forward-looking statements due to general economic conditions, and the risk
 factors detailed in IGI's periodic reports and registration statements filed
 with the Securities and Exchange Commission.
 
 SOURCE  IGI, Inc.